VentiRx Pharmaceuticals
Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune diseases.
General Information
Get notified when VentiRx Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track VentiRx Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About VentiRx Pharmaceuticals
Taxonomy: biopharmaceutical, clinical-stage, cancer treatment, respiratory diseases, autoimmune diseases, small molecule therapies, TLR8 agonists, TLR8 antagonists, vaccine adjuvants, oncology, allergy treatment, immune response stimulation, Celgene Corporation collaboration, Seattle headquarters, San Diego operations
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 5 |
|
23 Sep 2014 |
| Series A | •••••• | 4 |
|
13 Jan 2010 |
| Series A | •••••• | 1 |
|
06 Mar 2007 |
| Seed Round | •••••• | - | 01 Jan 2006 |
VentiRx Pharmaceuticals Alternatives & Competitors
Aviara Pharmaceuticals is a privately-held biopharmaceutical company focused on the development of s...
Innovative small molecule therapeutics for cancer and autoimmune disease treatment.
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early...
FAQ About VentiRx Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors VentiRx Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.